Cigarette smoke (CS) is a major risk factor for cardiovascular and lung diseases. Because CS is a complex aerosol containing more than 7,000 chemicals 1 it is challenging to assess the contributions of individual constituents to its overall toxicity. Toxicological profiles of individual constituents as well as mixtures can be however established in vitro, by applying high through-put screening tools, which enable the profiling of Harmful and Potentially Harmful Constituents (HPHCs) of tobacco smoke, as defined by the U.S. Food and Drug Administration (FDA).
Introduction
Toxicological risk assessment has historically relied on the use of animal models which, though fundamental in the life sciences, are also linked with shortcomings such as inconsistent translatability to humans and high cost. Furthermore, there has been an increasing effort to find alternatives to animal testing in the spirit of "The 3Rs" 2 (replacement, reduction, and refinement). This effort has been accelerated over the past few years, not only because of recent advances such as high-throughput techniques and systems biology approaches, but also because of legislation restricting the use of animal testing, especially in the European Union.
The complexity of cellular signaling pathways regulating the response to toxic insults makes it evident that using single toxicological endpoints will not be sufficient to describe the toxicological basis of certain compounds. For this, the interplay of hundreds of interacting proteins contributing to a biological network will also need to be taken into account. To study the effect of toxicants on those networks, a system toxicology approach combined with phenotypic medium-and high-throughput screening assays is useful to infer potencies and at the same time provide more information on the mechanism of action of individual toxicants.
In this study, we employed HCS as a powerful screening tool, which is composed of an automated microscope and a biological software application, that can acquire, process and analyze image data derived from specific fluorescence-based cellular assays. This allows for visual changes within a cell to be quantified, at a single cell or subcellular level, and many parameters to be analyzed simultaneously. 3 For example, 1. Obtain the AUC at position i is obtained by summing the areas of each rectangle, each rectangle being between two timepoints denoted by t k and t l (t k <t l ); calculate each rectangle area using x*y with x = t l -t k being the distance between two timepoints and y being the mean of the activity of the two timepoints (y = (NCI tk (i) + NCI tl (i)) / 2). Note: The AUC at 24 hr post-dosing for position i is denoted by AUC(i). As all the conditions are plated in triplicate wells the median of the three values is used.
Normalize the values using the following equation:
where i is the position in the 96 well plate for which AUC was calculated at 24 hr post-dosing, Vehicle is the median of the AUC values for the vehicle wells on a plate at 24 hr post-dosing, Positive control is the median of the AUC values for the positive control wells on a plate at 24 hr post-dosing, CR is the desired median normalized value for the vehicle (0%), and SC is the desired median normalized value for the positive controls (-100%) NOTE: At the end of this step, a data set is obtained that contains, for each position i in the 96 well plate, a concentration ci (in logarithmic units) that is applied to the sample contained in position/well i and its corresponding normalized AUC at 24 hr postdosing AUC_normalized(i). 
Measuring Toxicological Effects by HCS
NOTE: A total of nine multi-parametric markers of toxicity, grouped in six different assays, are measured using the HCS platform ( Table 1) . Based on the RTCA cell viability analysis (Section 2) the dose range of each constituent is defined and a 3R4F reference dose is also included. The reference dose is equivalent to the amount of HPHC present in the smoke of one stick from the reference cigarette 3R4F.
Seeding NHBE Cells
1. Prepare a cell suspension at 120,000 cells/ml (± 5%) and add 100 µl cell suspension to each well of a 96-well HCS plate (12,000 cells/ well). Prepare enough plates for the assessment of all assays (Cytotoxicity, DNA damage, Stress kinase, ROS, GSH content and Apoptosis) and timepoints (4 and 24 hr). Table 3 Figure 4b) , continue till a final serial dilution with 3 doses (d1, d2, and d3) and vehicle (V) for each positive control compound is obtained (Figure 4c) . To generate the positive control plate, prepare a 1:40 dilution of compounds in media (Figure 4d ).
HPHC Dilution (Compound Master Plate)
NOTE: The selected dose ranges of HPHCs for HCS are listed in Table 2 .
1. Dilute each HPHC stock solution (1 M) 1:10 in medium for a concentration of 100 mM. Perform dilutions using medium with 10% vehicle to obtain the selected 5x doses for each HPHC.
3. Dosing 1. Add 25 μl of 5x solutions from the compound master plate to the cells in triplicate maintaining the same dosing order as in the compound master plate (highest dose in the top row and vehicle control in the row number 7) ( Figure 5 ). Do not remove the existing (100 µl) cell culture medium. 2. Add 25 μl of 5x solution from the positive control plate to the cells in the bottom row maintaining the same dosing order as in the positive control plate ( Figure 5 ). Do not remove the existing (100 µl) cell culture medium. Note: Each assay has a specific positive control; see Table 3 . Incubate the plate at 37 °C and 5% CO 2 for the desired exposure time (4 or 24 hr).
4. Staining 1. Preparation for all Assays 1. Pre-warm the Wash buffer (PBS) solutions at 37 °C. 2. Prepare the Fixation solution (4% formaldehyde solution) adding 10.81 ml of 37% formaldehyde to 89.19 ml of wash buffer and pre-warm it at 37 °C. 3. Prepare the Permeabilization buffer by adding 10 ml of 10x permeabilization buffer to 90 ml of wash buffer and pre-warm it at 37°C . 4. Prepare the Blocking buffer by adding 10 ml of 10x blocking buffer to 90 ml of wash buffer and pre-warm it at 37 °C. 5. Pre-warm the Cell culture medium at 37 °C. 6. Remove the HCS plates from the incubator once the 4 and 24 hr exposure times are reached and perform the following specific protocols for each assay. . Dilute the anti-mouse antibody 1:500 in Secondary Antibody and Nuclear Solution. Dilute the Nuclear dye 1:1,000 in Secondary Antibody and Nuclear Solution. 12. Aspirate Primary Antibody Solution and wash plate three times with 100 μl/well of wash buffer using the plate washer. 13. Aspirate wash buffer and add 50 μl/well of Secondary Antibody and Nuclear Solution to each well of the plate(s) and incubate for 60 min at room temperature in the dark. 14. Aspirate Secondary Antibody and Nuclear Solution and wash plate three times with 100 μl/well of wash buffer using the plate washer. Add 100 μl/well of wash buffer. Plate(s) is (are) now ready to be evaluated on the HCS reader. 
Representative Results

RTCA
Because the HCS endpoints will not be informative when no toxic effect is detected, those compounds not showing decreased cell viability up to the highest concentration in the RCTA are not tested by HCS (Figure 3b,c,d,g,k,l,m,p) . Compounds showing decreased cell viability at only the highest concentration (Figure 3e,o) are also deselected for HCS. Finally, only the constituents with a computable LD 50 (< 20 mM) are selected for further HCS analysis (Figure 3a,f,h,j,n) . HPHCs meeting the above criteria are: 1-aminonaphtalene, Arsenic (V), Chromium (VI), Crotonaldehyde and Phenol.
HCS
As a Quality Check (QC), positive controls are first analyzed to assure that staining procedure is correctly performed. Representative pictures of positive control-treated cells are shown in Figure 6 . Data values are normalized to vehicle as previously described. No dose-response curves are plotted as only three doses are tested and not all the three doses are considered at every time-point. Positive control doses are selected (based on previous experiments, data not shown) so that appropriate responses are observed for each endpoint at both 4 hr and 24 hr. In particular doses 1 and 2 are used to evaluate the effect at 4 hr while doses 2 and 3 are used to evaluate the effect at 24 hr. Plates are discarded if no response is observed for the positive control doses. Note that for all the endpoints, except mitochondrial membrane potential and GSH content, an increase of the signal intensity is expected.
All compounds, except for Phenol, induced a necrotic phenotype, based on increased cell membrane permeability (Figure 7a,f,h,l) . 1-aminonaphtalene, Chromium (VI), Crotonaldehyde and Phenol were identified as being genotoxic based on increased phosphorylation of the histone H2AX (Figure 7e,j,n,p) . Phenol and 1-aminonaphtalene were found to induce severe mitochondrial dysfunction (Figure 7b ,o) which, with 1-aminonaphtalene, led to an increased cytochrome C release (Figure 7c) . Detection of increased caspase 3/7 activity provided evidence of apoptotic event upon chromium exposure. Oxidative stress induction (ROS or GSH) was also detected upon treatment with 1-aminonaphtalene, Crotonaldehyde and Phenol (Figure 7d,m,q) . Finally, Arsenic induces cell stress as demonstrated by the increased phosphorylation of the transcription factor cJun (Figure 7g ). 
Discussion
The needs for alternatives to animal experimentation and for new high throughput testing approaches have been widely discussed over the past years. This has led scientists and regulatory authorities to investigate alternative methods for standard toxicity testing, utilizing cellular assays that closely mimic the physiology of target tissues. In this study, we have demonstrated the applicability of combining a real-time cell analyzer (RTCA) with a high content screening (HCS) platform to assess the impact of exposure to single CS constituents on human lung epithelial cells. This setup could be analogously applied to evaluate cytotoxicity induced by various other airborne pollutants, airborne particles, and nanoparticles. Furthermore, the obtained results can be matched with those from whole-genome transcriptomics and computational methods based on causal biological networks. As previously reported, this approach allowed us to corroborate data on molecular pathway perturbation upon CS exposure 5 with HCS endpoints, addressing these pathway perturbations also phenotypically.
As a flowchart assay, real-time cell analysis provides cell viability-related information in a dose-and time-dependent resolution, which allows better decision making which dose and exposure time point may be favorable for downstream analysis 14 . The principle of the analyzer relies on changes in electrical impedance generated by the cells as they attach and spread on a culture well surface covered with a gold microelectrode. The impedance is converted into a dimensionless parameter named cell-index, which can be used to monitor cell adhesion, spreading, morphology and ultimately cell viability. Though this technique does not provide information on cytotoxic mechanisms, its sensitivity enables detection of morphological cellular changes even at very low doses at which the HCS is not informative (data not shown). Based on previous experiments, we have noted that RTCA methodology is able to detect morphological changes at lower doses compared to the HCS endpoints.
Following initial screening with the real-time cell analyzer, a HCS platform was used to gain more in-depth information on the kind of cytotoxicity elicited by each HPHC. The HCS assay panel allowed to profile HPHCs towards their potential impact on cellular compartments/organelles as well as to identify those eliciting genotoxicity or oxidative stress. The analysis revealed distinct profiles whereby the selected HPHCs induce cytotoxicity in NHBE cells. In general, all the compounds, except Phenol, were found to induce necrosis at the highest tested doses. Consistent with a potential role in cancer development 1-aminonaphtalene induced phosphorylation of H2AX as a marker for genotoxicity, however the HCS panel also uncovered activity of this HPHC in the mitochondrial toxicity readout (mass increased and cytochrome C release) and oxidative stress (GSH depletion). Similarly, as previously described, Phenol was identified to induce mitochondrial dysfunction, and cause DNA damage as well as GSH depletion. Chromium (VI), one of the compounds classified as group I carcinogens, and Crotonaldehyde were also both identified as genotoxic, in particular Chromium (VI) also induced apoptosis (caspase cascade activation) and Crotonaldehyde caused increased ROS generation. Finally Arsenic (V), was found to induce cJun phosphorylation which is a marker of stress kinase pathway activation.
In this study, we utilized NHBE cells as a model for lung epithelial cells in vitro. Using these cells in a HCS setting is unprecedented and enabled the investigation of a broader range of endpoints, including genotoxicity and oxidative stress markers. Both live cell and fixed cell staining approaches were described within our protocols, demonstrating the flexibility of the overall technique. In fact, the very same protocols can be applied to a broader range of targets, which can be addressed by the use of any fluorescent dye or antibody. For the successful execution of the live staining protocols, it is important to respect the incubation time, as some of the dyes have a limited half-life and the fluorescence signal may decrease before the image acquisition is completed. It is also important to consider that if a different cell type is used, all the staining conditions should be re-evaluated, as the optimal dye concentration and the incubation time may be different.
In the current paper we have described a scenario where only five compounds where screened with the HCS methodology. Considering the previously described plate layout, they were dosed over 2 different plate sets for a total of 24 plates (6 assays and 2 time-points).The number of plates could also be increased, thereby allowing for the simultaneous screening of more compounds or the investigation of more endpoints. Before doing so, however, one should take into consideration that certain endpoints (GSH and ROS) require immediate acquisition, and as a consequence, the dosing of the plates should be performed in a staggered fashion to permit the acquisition of the previous plate. On the other hand, using a fixed cell staining protocol represents an advantage as the plates can be stacked, interrupting the protocol at any step after the fixation, for completion of the staining procedure at a later stage. This approach, for example, would provide the operator with the time to complete all live cell staining plates without compromising the data quality.
To further optimize the workflow by decreasing the number of plates, it would also be possible to multiplex more endpoints together. For example in this context DNA Damage and Stress Kinase could be investigated together simply using two secondary antibody with fluorochromes emitting in different channels. Continuous development of the HCS platform, including fully automated cell seeding, compound dilution, dosing and staining, as well as the addition of new endpoints will further expand the capability of the HCS platform as a powerful profiling tool for HPHCs on epithelial and other cell types.
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